Day 2 :
Keynote Forum
Tayfun Uzbay
Uskudar University, Turkey
Keynote: Genoplasticity, brain and neuropsychiatric disorders
Time : 9:30am to 10:15am
Biography:
Abstract:
Keynote Forum
Yavuz Selim Silay
ICG ( Istanbul Consulting Group), Turkey
Keynote: The critical importance of new generation government engagement navigating government healthcare reforms and their impact in USA, Europe, Turkey & Emerging markets
Time : 10:15 to 11:00
Biography:
Abstract:
- Neuropsychiatry| Neuroprotection | Stroke Rehabilitation and Brain Hemorrhage
Location: Akdeniz 3
Chair
Engin KN,
Saglık University, Istanbul, Turkey
Session Introduction
Engin KN
Saglık University, Istanbul, Turkey
Title: Eye-to-visual-pathway integrity of glaucomatous neurodegeneration
Time : 11:15am-11:45 am
Biography:
Abstract:
Mufeed Al Jeady
Dallah Hospital, Saudi Arabia
Title: Role of modified barium swallow pre and post vitalStim therapy in the rehabilitation of the swallowing mechanism
Time : 11:45am- 12:15pm
Biography:
Abstract:
El Kaoui Habiba
University Ibn Tofail, Morocco
Title: Impact of a high fructose diet in wistar rat–metabolic and behavioral disorders –effect of supplementation of flaxseed
Biography:
Abstract:
Soma Sengupta
Emory University, Georgia
Title: Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death
Time : 13:15pm- 14:00pm
Biography:
Abstract:
Yavuz Selim SILAY and Ali Kurt
Chairman of ICG İstanbul Aydın University, Turkey
Title: How to Innovate in medicine in a university Setting? Biocube Ä°stanbul bioentrepreneurship and innovation center as a global case example
Biography:
Dr. Ali Kurt a global innovation management leader and Dr. Yavuz Selim SILAY a global physician leader and seasoned expert in Healthcare Innovation, Physician Entrepreneurship, Government engagement, Commercial Diplomacy, Corporate Communications, Government affairs & Medical Affairs will discuss how BioCube Ä°stanbul has been established and current engagements with academicians Venture Capital and angel Investtment networks for commercializing healthcare technologies will be discussed.
Abstract:
Large Pharmaceutical, Biotech and Medical Device companies are constantly evaluating how to work with universities and startup companies and utilize their know how. Istanbul Consulting Group recently worked with Istanbul Aydın University to establish a thematic program in Healthcare Bioentrepreneurship which has taken the road with the slogan of "Towards a Bright Future", at the brightest spots of business life. Istanbul Aydın University is a city and campus university located in the center of Istanbul with its experienced academic staff who have gained a reputation for their scientific studies globally. At BioCube İstanbul several healthcare startup companies are flourishing thanks to the coordination of Technology Transfer and Project Managament offices succesful coordination on innovation management with all key stakeholders To gain these critical insights for Thematic Management of Healthcare Bioentrepreneurship and Innovation Track in Universities and how to accelerate innovations in order to improve healthcare. We seek to empower entrepreneur academicians, doctors, other healthcare providers and with the information, resources, connections, and experience they need to commercialize their ideas, inventions and discoveries. Currrent Trends in Innovation Management in Medicine in a University Setting and the BioCube İstanbul Bioentrepreneurship and Innovation Centeras a global case for USA Europe Turkey and Emerging Markets will be provided with unique cases.
Mohammad Alhasan
Qasseem National Hospital, Saudi Arabia
Title: Diagnosis and management of transient ischemic attack
Time : 15:15pm-15:45pm
Biography:
Educational
2004: Aleppo University - Medical School, Bachelor of Medicine- Syria
2009: Syrian BOARD in Neurology Disease, Syria.
Professional:
2011 untill now : Neurology Specialist
Qaseem National Hospital – Saudi Arabia
Abstract:
This presentation reviews the diagnosis, investigation, and recommended management after a transient ischemic attack (TIA). Up to a 10% risk of recurrent stroke exists after a TIA, and up to 80% of this risk is preventable with urgent assessment and treatment. Imaging of the brain and intracranial and extracranial blood vessels using CT, CT angiography, carotid Doppler ultrasound, and MRI is an important part of the diagnostic assessment. Treatment options include anticoagulation for atrial fibrillation, carotid revascularization for symptomatic carotid artery stenosis, antiplatelet therapy, and vascular risk factor reduction strategies. TIA offers the greatest opportunity to prevent stroke that physicians encounter. A TIA should be treated as a medical emergency, as up to 80% of strokes after TIA are preventable.